tiprankstipranks
Trending News
More News >
Teijin Limited (JP:3401)
:3401
Advertisement

Teijin (3401) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3401

Teijin

(3401)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 4o)
Rating:55Neutral
Price Target:
¥1,241.00
▼(-4.39% Downside)
Teijin's overall stock score reflects a combination of mixed financial performance, bearish technical indicators, and attractive valuation metrics. The most significant factor is the financial performance, which highlights challenges in revenue growth and profitability. Technical analysis indicates weak momentum, while the valuation suggests the stock is undervalued with a good dividend yield. The absence of earnings call data and corporate events means these factors did not influence the score.
Positive Factors
Innovative Product Portfolio
Teijin's focus on advanced materials like aramid and carbon fibers positions it well in high-demand sectors like automotive and aerospace, supporting long-term growth.
Sustainability Focus
Teijin's emphasis on eco-friendly materials aligns with global trends towards sustainability, enhancing its market appeal and growth prospects.
Cash Generation
Improved cash generation capabilities provide Teijin with resources to invest in growth opportunities and manage financial obligations effectively.
Negative Factors
Revenue Decline
Declining revenue growth indicates potential market challenges or competitive pressures, necessitating strategic adjustments to regain momentum.
Rising Debt Levels
Increasing debt levels could strain Teijin's financial flexibility, impacting its ability to invest in growth and manage economic downturns.
Profitability Challenges
Decreasing profit margins suggest cost pressures or pricing challenges, which could affect long-term profitability if not addressed.

Teijin (3401) vs. iShares MSCI Japan ETF (EWJ)

Teijin Business Overview & Revenue Model

Company DescriptionTeijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide. It offers aramid fibers and polyethylene materials; carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. The company also provides PC resins, polyphenylene sulfide resins, molded parts, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, it offers pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, rehabilitation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system; and orthopedic implantable devices, and functional food ingredients. Further, the company provides Recopic, a radio-frequency identification technology for inventory management. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyTeijin generates revenue through several key streams, primarily from the sale of high-performance materials, including aramid and carbon fibers, which are critical in industries such as automotive and aerospace. The company also earns income from its healthcare division, which offers pharmaceutical products and medical devices. Additionally, Teijin benefits from partnerships with major industrial players and investments in research and development, allowing it to create specialized and high-value products tailored to market demands. The company's focus on sustainability and innovation further drives its growth, as it capitalizes on the increasing demand for eco-friendly materials and solutions.

Teijin Earnings Call Summary

Earnings Call Date:Feb 06, 2025
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Feb 11, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted a positive turnaround in net income and an improved operating income forecast. However, significant challenges remain in the Materials and Healthcare segments, with operational issues in the Composites and Aramid businesses. The company faces external pressures from strikes and generic competition but is taking steps to improve profitability.
Q3-2024 Updates
Positive Updates
Positive Net Income Turnaround
Net income was JPY 3.5 billion, turning black from the previous year's loss.
Improved Operating Income Forecast
Operating income is expected to be JPY 18 billion for the full year, up slightly less than 40% from the previous year.
Fibers & Products Segment Growth
Operating income increased by JPY 1.4 billion from the previous year to JPY 9.3 billion in the Fibers & Products segment.
Insurance Income
The company recorded insurance income from the Aramid business fire of more than JPY 5 billion.
Strong Performance in IT Segment
The IT segment saw a JPY 0.9 billion increase in profit over the previous year, with strong sales in the Internet business field.
Negative Updates
Materials Business Loss
The materials business remains at an operating income level of negative JPY 5.8 billion.
Healthcare Business Decline
The Healthcare business saw a JPY 19.2 billion decrease in operating profit over the previous year, with a subdued level of JPY 1.8 billion.
Impact of UAW Strike and Equipment Failures
The Composites business was affected by the UAW strike and recurring equipment breakdowns, leading to operational challenges.
Aramid Business Sales Decline
Sales volume in the Aramid business decreased due to inventory adjustments by customers and a slowdown in demand since November.
Negative Impact from Generic Alternatives
The entry of a generic version of FEBURIC affected the Healthcare segment, resulting in a significantly lower forecast over the previous year.
Company Guidance
In the earnings call for the third quarter of 2024, company executives Eiji Ogawa and Akimoto Uchikawa provided a detailed analysis of financial performance and strategic initiatives. For the first nine months of the fiscal year, net sales remained steady at JPY 759.6 billion, while operating income fell by JPY 10 billion to JPY 4.9 billion, mainly due to a one-off contract fee. The company's net income turned positive at JPY 3.5 billion, reversing last year's loss. The full-year forecast predicts net sales of JPY 1,030 billion and operating income of JPY 18 billion, which is a 40% increase from the previous year but JPY 17 billion below the earlier forecast. Uchikawa discussed the profitability improvement measures, with a focus on underperforming sectors like Composites and Healthcare, aiming for JPY 19 billion in profit improvements. Despite challenges like the UAW strike and equipment failures in North America, some segments, such as Fibers & Products, showed robust performance with a JPY 1.4 billion increase in operating income to JPY 9.3 billion. The Healthcare business, however, saw a JPY 19.2 billion drop in operating profit, influenced by the entry of a generic competitor to their main drug. The executives also highlighted ongoing efforts to stabilize gas prices and improve productivity, with a strategic focus on addressing low ROE and enhancing shareholder value.

Teijin Financial Statement Overview

Summary
Teijin's financial statements present a mixed picture. The income statement reveals challenges in revenue growth and profitability, with negative EBIT and EBITDA margins. The balance sheet shows moderate stability but rising debt levels, which could pose future risks. The cash flow statement indicates positive trends in cash generation but highlights the need for better cash conversion efficiency. Overall, Teijin needs to focus on improving operational efficiency, managing leverage, and enhancing cash flow conversion to strengthen its financial position.
Income Statement
45
Neutral
Teijin's income statement shows a mixed performance. The company has experienced a decline in revenue growth, with a negative growth rate in the TTM period. Gross profit margins have decreased over time, indicating potential challenges in cost management or pricing power. The net profit margin remains positive but is relatively low, suggesting limited profitability. EBIT and EBITDA margins are negative, highlighting operational inefficiencies or high fixed costs. Overall, the income statement reflects a need for strategic improvements to enhance revenue growth and profitability.
Balance Sheet
55
Neutral
The balance sheet of Teijin presents a moderate financial position. The debt-to-equity ratio is below 1, indicating a balanced approach to leveraging, but it has increased over time, suggesting rising debt levels. Return on equity is positive but modest, reflecting moderate efficiency in generating returns for shareholders. The equity ratio is stable, showing a reasonable proportion of equity financing. However, the increasing debt levels could pose a risk if not managed carefully. Overall, the balance sheet indicates stability but with potential leverage concerns.
Cash Flow
60
Neutral
Teijin's cash flow statement shows some positive trends. The free cash flow growth rate is positive in the TTM period, indicating improved cash generation capabilities. The operating cash flow to net income ratio is stable, suggesting consistent cash flow relative to earnings. However, the free cash flow to net income ratio is relatively low, indicating limited cash conversion from profits. While there are improvements in cash flow generation, the company needs to enhance its cash conversion efficiency. Overall, the cash flow statement reflects a positive trajectory with room for further optimization.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue993.29B1.01T1.03T1.02T926.05B836.51B
Gross Profit183.89B191.45B275.77B218.76B241.27B241.33B
EBITDA-9.18B4.37B118.08B80.51B116.13B64.02B
Net Income23.19B28.35B10.60B-17.70B23.16B-6.66B
Balance Sheet
Total Assets1.15T1.06T1.25T1.27T1.24T1.07T
Cash, Cash Equivalents and Short-Term Investments205.36B116.04B137.75B142.78B134.48B170.19B
Total Debt492.20B387.13B495.72B529.42B485.17B380.04B
Total Liabilities709.01B622.73B769.09B821.37B774.20B643.95B
Stockholders Equity431.83B431.38B454.59B425.66B440.38B407.05B
Cash Flow
Free Cash Flow14.58B8.42B4.41B-2.65B-110.82B46.80B
Operating Cash Flow77.83B69.84B69.45B55.09B89.66B107.73B
Investing Cash Flow51.02B52.52B-46.05B-52.43B-198.38B-79.59B
Financing Cash Flow-81.05B-134.46B-43.16B7.18B71.11B-20.88B

Teijin Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1298.00
Price Trends
50DMA
1295.78
Positive
100DMA
1272.56
Positive
200DMA
1232.28
Positive
Market Momentum
MACD
-1.61
Negative
RSI
52.32
Neutral
STOCH
60.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3401, the sentiment is Positive. The current price of 1298 is above the 20-day moving average (MA) of 1270.58, above the 50-day MA of 1295.78, and above the 200-day MA of 1232.28, indicating a bullish trend. The MACD of -1.61 indicates Negative momentum. The RSI at 52.32 is Neutral, neither overbought nor oversold. The STOCH value of 60.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3401.

Teijin Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
€146.23B12.158.27%2.86%-2.45%7.31%
77
Outperform
¥120.70B10.663.30%-1.63%67.13%
73
Outperform
$386.46B12.5613.63%2.10%-1.33%9.21%
73
Outperform
¥231.81B12.773.74%2.65%7.16%
69
Neutral
$919.31B25.1113.77%0.98%6.71%-14.98%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
55
Neutral
$248.95B9.28-20.43%3.73%-8.20%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3401
Teijin
1,306.50
50.96
4.06%
JP:5393
Nichias
6,332.00
637.39
11.19%
JP:5706
Mitsui Mining and Smelting Company
17,525.00
12,854.56
275.23%
JP:5331
Noritake Co.,Limited
5,420.00
1,746.03
47.52%
JP:3106
KURABO INDUSTRIES LTD.
7,710.00
2,245.36
41.09%
JP:4206
Aica Kogyo Company, Limited
3,412.00
356.82
11.68%

Teijin Corporate Events

Teijin Limited Reports Decline in Revenue and Income
Nov 5, 2025

Teijin Limited is a diversified Japanese company operating primarily in the materials, fibers, and healthcare sectors, known for its innovative solutions in advanced materials and pharmaceuticals. In its latest earnings report for the six months ending September 30, 2025, Teijin reported a decline in revenue and adjusted operating income compared to the previous year, reflecting ongoing challenges in its core markets. Key financial metrics revealed a revenue of 451,043 million yen, down 11.1% year-on-year, and an adjusted operating income of 13,042 million yen, marking a 30% decrease. The company also faced a significant operating loss of 54,082 million yen, primarily due to impairment losses in its Materials segment. Despite these challenges, Teijin maintained its dividend outlook, signaling a commitment to shareholder returns. Looking ahead, Teijin’s management remains cautious, revising its full-year forecast to reflect a continued challenging environment, with expectations of a 14.5% decline in annual revenue. The company is focusing on strategic restructuring and cost management to navigate the current market conditions.

Teijin Limited Reports Decreased Income and Adjusted Outlook for FY2025
Nov 5, 2025

Teijin Limited reported a decrease in adjusted operating income for the second quarter of FY2025, primarily due to maintenance in its Materials Business and impairment losses in the aramid sector. The outlook for FY2025 anticipates further income reduction due to delayed recovery in the Materials Business and the transfer of the aramid paper business, though dividends remain unchanged.

The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1356.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.

Teijin Revises Earnings Forecasts Amid Aramid Business Challenges
Nov 5, 2025

Teijin Limited has revised its full-year earnings forecasts for the fiscal year ending March 31, 2026, due to recent performance challenges. The company has recorded significant impairment losses in its aramid business, driven by intensified competition and unfavorable exchange rate fluctuations. Despite these setbacks, Teijin plans to maintain its dividend forecast, emphasizing its commitment to stable shareholder returns.

The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1356.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.

Teijin Reports Decline in Financial Performance for H1 2025
Nov 5, 2025

Teijin Limited reported a decline in its financial performance for the six months ending September 30, 2025, with revenue and adjusted operating income both falling compared to the previous year. The company has revised its outlook for the fiscal year ending March 31, 2026, indicating challenges in achieving its financial targets, which may impact its market positioning and stakeholder confidence.

The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1356.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.

Teijin Limited Reports Minor Impact from Delfzijl Plant Fire
Oct 29, 2025

Teijin Limited reported a fire incident at its Delfzijl plant in the Netherlands, operated by its subsidiary Teijin Aramid B.V. The fire, caused by a problem with drying equipment, was extinguished without any injuries or environmental impact. The plant resumed operations safely by August 20, and the company has implemented measures to prevent future incidents. The financial impact of the incident is expected to be minor, with the production system prepared to meet upcoming sales demands.

The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1356.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.

Teijin Transfers Shares in Aramid Paper Joint Ventures to DuPont
Aug 29, 2025

Teijin Limited has announced its decision to transfer its shares in DuPont Teijin Advanced Papers (Japan) Limited and DuPont Teijin Advanced Papers (Asia) Limited to DuPont de Nemours, Inc. This move comes as part of DuPont’s exit from its aramid operations and aligns with Teijin’s strategy to streamline its business portfolio and focus on future growth areas. The share transfer is expected to enhance Teijin’s competitiveness and maximize corporate value over the medium to long term.

The most recent analyst rating on (JP:3401) stock is a Buy with a Yen1434.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.

Fire Incident at Teijin’s Delfzijl Plant: Impact Under Investigation
Aug 7, 2025

Teijin Limited announced a fire incident at its Delfzijl plant in the Netherlands, operated by its subsidiary Teijin Aramid B.V. The fire, which occurred on August 6, 2025, was extinguished without any reported injuries, but the extent of physical damage and its impact on production and financial outlook are still being assessed. The incident could potentially affect Teijin’s operations and market positioning, with further disclosures expected as investigations continue.

The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1280.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025